San Antonio Breast Cancer Symposium
- Conference News
- Frontline Medical News
- Oncology
- San Antonio Breast Cancer Symposium
- Top News Stories
- Women's Health
Extra years of adjuvant bisphosphonate not needed in early breast cancer
REPORTING FROM SABCS 2017 SAN ANTONIO (FRONTLINE MEDICAL NEWS) – When it comes to ...
Adjuvant trastuzumab for 1 year remains standard of care for early HER2+ breast cancer
REPORTING FROM SABCS 2017 SAN ANTONIO (FRONTLINE MEDICAL NEWS) – The phase 3 SOLD ...
2 = 5 for additional AI therapy for postmenopausal HR+ breast cancer
REPORTING FROM SABCS 2017 SAN ANTONIO (FRONTLINE MEDICAL NEWS) – Five years of additional ...
Acupuncture significantly reduces AI-associated arthralgias
REPORTING FROM SABCS 2017 SAN ANTONIO (FRONTLINE MEDICAL NEWS) – Acupuncture significantly reduced joint ...
- Conference News
- Frontline Medical News
- Oncology
- San Antonio Breast Cancer Symposium
- Top News Stories
- Women's Health
No evidence for perioperative AI benefit in early ER/PR+ breast cancer
REPORTING FROM SABCS 2017 SAN ANTONIO (FRONTLINE MEDICAL NEWS) – Skip the perioperative aromatase ...
Dose intensification gets more mileage out of adjuvant chemo
REPORTING FROM SABCS 2017 SAN ANTONIO (FRONTLINE MEDICAL NEWS) – Increasing the dose intensity ...
Ribociclib plus standard of care improves PFS in premenopausal HR+/HER2-negative breast cancer
REPORTING FROM SABCS 2017 SAN ANTONIO (FRONTLINE MEDICAL NEWS) – For premenopausal women with ...
Novel ADC shows promise in metastatic triple-negative breast cancer
REPORTING FROM SABCS 2017 SAN ANTONIO (FRONTLINE MEDICAL NEWS) – A novel antibody drug ...
No benefit to trastuzumab in low HER2 breast cancer
REPORTING FROM SABCS 2017 SAN ANTONIO (FRONTLINE MEDICAL NEWS) – Adding trastuzumab to the ...
Circulating microRNAs may predict breast cancer treatment response
AT SABCS 2016 SAN ANTONIO (FRONTLINE MEDICAL NEWS) – Circulating microRNAs may predict treatment ...
CTCs help predict breast cancer outcomes in neoadjuvant setting
AT SABCS 2016 SAN ANTONIO (FRONTLINE MEDICAL NEWS) – Circulating tumor cells are a ...
Gene, risk signatures could predict PARP inhibitor response in breast cancer
AT SABCS 2016 SAN ANTONIO (FRONTLINE MEDICAL NEWS) – PARPi 7, BRCAness, and MammaPrint ...
- Conference News
- Frontline Medical News
- Oncology
- San Antonio Breast Cancer Symposium
- Surgery
- Women's Health
SLND after neoadjuvant chemo is feasible, but more study needed
At SABCS 2016 SAN ANTONIO (FRONTLINE MEDICAL NEWS) – Sentinel lymph node detection after ...